American Association for Cancer Research

SHERPA: Unknown

People

  1. Berger
    Berger
  2. Ladanyi
    Ladanyi
  3. Razavi
    Razavi
  4. Schultz
    Schultz
  5. Solit
    Solit
  6. Drilon
    Drilon
  7. Rudin
    Rudin
  8. Chandarlapaty
    Chandarlapaty
  9. Riely
    Riely
  10. Schram
    Schram

Groups

  1. Hematology-Oncology Fellows (253)
  2. Department of Medicine (242)
  3. Solid Tumor Oncology Division (218)
  4. Weinberg Fellows (182)
  5. GSK Faculty (174)
  6. Human Oncology and Pathogenesis Program (129)
  7. Sloan Kettering Institute Postdocs (127)
  8. Department of Pathology and Laboratory Medicine (122)
  9. Center for Molecular Imaging and Biotechnology (CMIB) (110)
  10. Hematologic Malignancies, Division of (91)
Search Within
  1. "Hematology-Oncology Fellows"
Formats
  1. Meeting Abstract (121)
  2. Journal Article (116)
  3. Editorial (10)
  4. Review (5)
  5. Correspondence (1)
Groups
  1. Hematology-Oncology Fellows (253)
  2. Department of Medicine (242)
  3. Solid Tumor Oncology Division (218)
  4. Weinberg Fellows (182)
  5. GSK Faculty (174)
  6. Human Oncology and Pathogenesis Program (129)

More Groups

People
  1. Michael Berger (43)
  2. Marc Ladanyi (35)
  3. Pedram Razavi (30)
  4. David Hyman (28)
  5. David Solit (28)
  6. Nikolaus Schultz (28)

More People

Years
  1. 2025 (10)
  2. 2024 (15)
  3. 2023 (20)
  4. 2022 (61)
  5. 2021 (32)
  6. 2020 (42)

More Years

Publications
  1. Clinical Cancer Research (128)
  2. Cancer Research (125)

Results (253)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Unsupervised graph-based visualization of variational autoencoder latent spaces reveals hidden multiple myeloma subtypes
    Meeting Abstract

    Simhal, A. K.; Elkin, R.; Firestone, R. S.; Oh, J. H.; Deasy, J. O.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • ctDNA analysis in ERBB2-amplified colorectal cancer: Biomarker analysis of the MyPathway trial
    Journal Article

    Meric-Bernstam, F.; Raghav, K. P. S.; Sweeney, C. J.; Swanton, C.; Spigel, D. R.; Bose, R.; Burris, H. A.; Friedman, C. F.; Espenschied, C. R.; Grindheim, J. M.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • A phase II study of fulvestrant plus abemaciclib in hormone receptor–positive advanced or recurrent endometrial cancer
    Journal Article

    Green, A. K.; Zhou, Q.; Iasonos, A.; Zammarrelli, W. A. 3rd; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Loh, J.; Hom, V.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Clinical implications of the cancer genome atlas molecular classification system in esophagogastric cancer
    Journal Article

    Walch, H. S.; Borpatragohain, R.; Jee, J.; Chatila, W.; Fong, C.; Maron, S. B.; Ku, G. Y.; Ilson, D. H.; Janjigian, Y. Y.; Wu, A. J.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Safety and tolerability of lete-cel in NSCLC—Reply
    Correspondence

    Altan, M.; Lopes, G.; Hiltermann, T. J. N.; Govindan, R.; Villaruz, L. C.; Calvo, E.; Edelman, M. J.; Furqan, M.; Neal, J.; Felip, E.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • A phase I dose-escalation study of the HIF-2 alpha inhibitor DFF332 in patients with advanced clear-cell renal cell carcinoma
    Journal Article

    Pal, S. K.; Bernard-Tessier, A.; Grell, P.; Gao, X.; Kotecha, R. R.; Picus, J.; de Braud, F.; Takahashi, S.; Wong, A.; Suárez, C.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Can longitudinal biomarkers guide treatment decisions? Time will tell
    Editorial

    Jeng, M. Y.; Schoenfeld, A. J.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Safety and tolerability of letetresgene autoleucel (GSK3377794): Pilot studies in patients with advanced non–small cell lung cancer
    Journal Article

    Altan, M.; Lopes, G.; Hiltermann, T. N. J.; Govindan, R.; Villaruz, L. C.; Calvo, E.; Edelman, M. J.; Furqan, M.; Neal, J.; Felip, E.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Analysis of shared variants between cancer biospecimens
    Journal Article

    Foote, M. B.; White, J. R.; Chatila, W. K.; Argilés, G.; Lu, S.; Rousseau, B.; Artz, O.; Johannet, P.; Walch, H.; Patel, M.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Divergent clinical and immunologic outcomes based on STK11 Co-mutation status in resectable KRAS-mutant lung cancers following neoadjuvant immune checkpoint blockade
    Journal Article

    Rosner, S.; Connor, S.; Sanber, K.; Zahurak, M.; Zhang, T.; Gurumurthy, I.; Zeng, Z.; Presson, B.; Singh, D.; Rayes, R.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: